(PharmaNewsWire.Com, January 22, 2018 ) According to Publisher, the Global Pyrogen Testing market is accounted for $632.19 million in 2016 and is expected to reach $1,631.84 million by 2023 growing at a CAGR of 14.5% from 2016 to 2023. Rapidly growing healthcare, pharmaceutical and biotechnology industries are primarily favouring the pyrogen testing market. Furthermore, favorable government policies, discovery of new innovative drugs and high incidence of chronic diseases are the factors enhancing market growth. However, strict regulatory norms and high degree consolidation in pharmaceutical industry are limiting the growth of pyrogen testing market. Pharmaceutical outsourcing and rapidly developing healthcare infrastructure in emerging countries offer tremendous growth opportunities for key players in the global market.
Pyrogen Test is an obsolete test of the adequacy of the hypothalamic-adenohypophysis-adrenocortical axis, in which timed doses of bacterial pyrogen evoke an increase in plasma cortisol in normal subjects. Kits & reagents segment is likely to acquire the highest market share during the forecast period and is also expected to grow at a higher CAGR. The growth of this segment is attributed to rising adoption and repeat purchase of these products. By test type, in vitro tests segment is expected to witness high growth rate during the forecast period.
North America is anticipated to be the largest market for pyrogen testing and Asia Pacific is projected to grow at a faster pace. The maximum share was attributable to the strong presence of key players in the region, who are making big investments in research and development. The growth of APAC is attributed to the increasing population, developing healthcare infrastructure, rising disposable income, availability of manpower at cheaper rate and outsourcing by key players in developed nations.
Some of the key players in this market include Lonza Group, Wako Chemicals USA, Inc., Merck & Co., Inc., Waters Corporation, Ellab A/S, WUXI Pharmatech (Cayman) Inc., Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, Hyglos Gmbh, Associates of Cape Cod, Inc., Genscript, Charles River Laboratories International, Inc. Pyrostar, Microcoat Biotechnologie GmbH and Sanquin.
Applications Covered: -Biological and Biotechnological Industry -Healthcare Industry -Pharmaceutical Industry -Medical Device Manufacturing Industry -Other Applications
Test Types Covered: -Rabbit Pyrogen Test (RPT) -In Vitro Tests -Monocyte Activation Test (MAT) -Recombinant Factor C Assay (rFC) -Limulus Amoebocyte Lysate (LAL) Tests
Products Covered: -Kits and Reagents -Services -Instruments -Consumables
Regions Covered: -North America -US -Canada -Mexico -Europe -Germany -UK -Italy -France -Spain -Rest of Europe -Asia Pacific -Japan -China -India -Australia -New Zealand -Rest of Asia Pacific -South America -Argentina -Brazil -Chile -Rest of South America -Middle East & Africa -Saudi Arabia -UAE -Qatar -South Africa -Rest of Middle East & Africa
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
